UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Drug testing and analysis, 2014-07, Vol.6 (7-8), p.614-632

2014

Volltextzugriff (PDF)

Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

Nature communications, 2023-12, Vol.14 (1), p.8221-8221, Article 8221

2023

Volltextzugriff (PDF)

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Psychopharmacology, 2019-02, Vol.236 (2), p.799-808

2019

Volltextzugriff (PDF)

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

PloS one, 2016-06, Vol.11 (6), p.e0157021

2016

Volltextzugriff (PDF)

Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection

Pharmaceutics, 2022-03, Vol.14 (3), p.556

2022

Volltextzugriff (PDF)

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

Metabolites, 2024-05, Vol.14 (5), p.270

2024

Volltextzugriff (PDF)

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Current neuropharmacology, 2017-07, Vol.15 (5), p.692-712

2017

Volltextzugriff (PDF)

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Drug testing and analysis, 2018-02, Vol.10 (2), p.310-322

2018

Volltextzugriff (PDF)

Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2014-01, Vol.10 (8), p.843

2014

Volltextzugriff (PDF)

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Neuropharmacology, 2020-05, Vol.167, p.107933-107933, Article 107933

2020

Volltextzugriff (PDF)

Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)

Drug testing and analysis, 2017-10, Vol.9 (10), p.1641-1649

2017

Volltextzugriff (PDF)

Syntheses and Pharmacological Evaluations of Novel N-Substituted Bicyclo-Heptane-2-amines at N-Methyl-d-Aspartate Receptors

Chemical biology & drug design, 2011-07, Vol.78 (1), p.25-32

2011

Volltextzugriff (PDF)

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

New Psychoactive Substances, 2018-01, p.305-352

2018

Volltextzugriff (PDF)

The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites

Journal of psychoactive drugs, 2023-05, Vol.55 (3), p.354-358

2023

Volltextzugriff (PDF)

Phencyclidine-Based New Psychoactive Substances

New Psychoactive Substances, 2018-01, Vol.252, p.261-303

2018

Volltextzugriff (PDF)

The Pharmacokinetics of Ketamine in the Breast Milk ofLactating Women: Quantification of Ketamine and Metabolites

Journal of psychoactive drugs, 2023-07, Vol.55 (3), p.354-358

2023

Volltextzugriff (PDF)

Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties

Neuropharmacology, 2017-01, Vol.112 (Pt A), p.144-149

2017

Volltextzugriff (PDF)

First Reported Fatalities Associated with the ‘Research Chemical’ 2-Methoxydiphenidine

Journal of analytical toxicology, 2015-05, Vol.39 (4), p.287-293

2015

Volltextzugriff (PDF)

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)

Drug testing and analysis, 2016-09, Vol.8 (9), p.891-902

2016

Volltextzugriff (PDF)

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)

Drug testing and analysis, 2019-08, Vol.11 (8), p.1122-1133

2019

Volltextzugriff (PDF)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs

Drug design, development and therapy, 2017-01, Vol.11, p.1369-1382

2017

Volltextzugriff (PDF)

Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Psychopharmacology, 2019-02, Vol.236 (2), p.809-809

2019

Volltextzugriff (PDF)

Return of the lysergamides. Part III: Analytical characterization of N 6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)

Drug testing and analysis, 2017-10, Vol.9 (10), p.1641-1649

2017

Volltextzugriff (PDF)

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)

Drug testing and analysis, 2020-06, Vol.12 (6), p.812-826

2020

Volltextzugriff (PDF)

Pharmacological characterizations of the 'legal high' fluorolintane and isomers

European journal of pharmacology, 2019-08, Vol.857, p.172427-172427, Article 172427

2019

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(55)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Pharmacology & Pharmacy
(24)
Humans
(19)
Animals
(16)
Physical Sciences
(16)
Biochemistry & Molecular Biology
(15)
Chemistry
(15)
Chemistry, Analytical
(15)
Biochemical Research Methods
(13)
Male
(13)
New Psychoactive Substances
(10)
Rats
(9)
Ketamine
(8)
Lsd
(7)
Lysergic Acid Diethylamide - Analogs & Derivatives
(7)
Neurosciences
(7)
Psychedelics
(7)
Drug Testing
(6)
Lysergamides
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues

Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection

In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)

Syntheses and Pharmacological Evaluations of Novel N-Substituted Bicyclo-Heptane-2-amines at N-Methyl-d-Aspartate Receptors

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites

Phencyclidine-Based New Psychoactive Substances

The Pharmacokinetics of Ketamine in the Breast Milk ofLactating Women: Quantification of Ketamine and Metabolites

Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties

First Reported Fatalities Associated with the ‘Research Chemical’ 2-Methoxydiphenidine

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs

Correction to: Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

Return of the lysergamides. Part III: Analytical characterization of N 6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)

Pharmacological characterizations of the 'legal high' fluorolintane and isomers

Suchergebnisse filtern